Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,779 | -37,814 | -197,723 | -142,676 | -91,585 |
| Depreciation Amortization | 1,038 | 642 | 2,730 | 2,065 | 1,326 |
| Other Working Capital | -11,908 | -16,339 | 5,438 | 5,575 | 2,882 |
| Other Operating Activity | 27,780 | 13,842 | 43,025 | 29,547 | 16,904 |
| Operating Cash Flow | $-61,869 | $-39,669 | $-146,530 | $-105,489 | $-70,473 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -220 | -214 | -1,041 | -629 | -495 |
| Investing Cash Flow | $-220 | $-214 | $-1,041 | $-629 | $-495 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 155,574 | 14,072 | 24,596 | 24,596 | N/A |
| Other Financing Activity | 0 | 0 | 95,446 | 95,446 | 95,446 |
| Financing Cash Flow | $155,574 | $14,072 | $120,042 | $120,042 | $95,446 |
| Beginning Cash Position | 155,890 | 155,890 | 183,419 | 183,419 | 183,419 |
| End Cash Position | 249,375 | 130,079 | 155,890 | 197,343 | 207,897 |
| Net Cash Flow | $93,485 | $-25,811 | $-27,529 | $13,924 | $24,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,869 | -39,669 | -146,530 | -105,489 | -70,473 |
| Capital Expenditure | -220 | -214 | -1,041 | -629 | -495 |
| Free Cash Flow | -62,089 | -39,883 | -147,571 | -106,118 | -70,968 |